Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.55 |
| ▸ | CXCL8 | P10145 | 2/20 | 0.54 |
| ▸ | ALB | P02768 | 1/20 | 0.52 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.51 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.51 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.51 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.47 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.45 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.44 |
| ▸ | ERN1 | O75460 | 1/20 | 0.42 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.42 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.42 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.42 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.42 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.42 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7937087 | 0.85 | AKR1B1 (0.67) | AKR1B1CXCL8ALBDUSP3PTPN5 | |
| SCHEMBL28357376 | 0.82 | ANO1 (0.47) | CXCL8ALBANO1HMGB1ERN1 | |
| SCHEMBL723768 | 0.82 | CXCL8 (0.56) | AKR1B1CXCL8DUSP3PTPN5PTPN11 | |
| SCHEMBL8645 | 0.81 | CXCL8 (0.65) | AKR1B1CXCL8TDP1PTGS2KDM4E | |
| SCHEMBL29533621 | 0.81 | CXCL8 (0.65) | AKR1B1CXCL8TDP1PTGS2KDM4E | |
| SCHEMBL27996630 | 0.81 | ALB (0.48) | ALBHMGB1 | |
| SCHEMBL11118766 | 0.80 | CXCL8 (0.77) | AKR1B1CXCL8DUSP3PTPN5PTPN11 | |
| SCHEMBL7165040 | 0.80 | CXCL8 (0.77) | AKR1B1CXCL8ALBPTGS2 | |
| SCHEMBL28134586 | 0.80 | CXCL8 (0.54) | AKR1B1CXCL8DUSP3PTPN5PTPN11 | |
| SCHEMBL28005176 | 0.79 | IAPP (0.47) | CXCL8ALBANO1HMGB1ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060148858-A1 | 1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060148858-A1 | 1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity | GPR119, SLC5A1, CYP4B1 | AKR1B1 101/4885CXCL8 4247/4885ALB 1373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.